# THERMO FISHER SCIENTIFIC INC. (TMO) FY2026 YTD Q2 P&L / Income Statement - Company: THERMO FISHER SCIENTIFIC INC. (TMO) - Period: 2026-01-01 to 2026-06-27 - Filing: Q2 FY2026 10-Q, filed 2026-07-31, accession number 0000097745-26-000144 - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service (3 categories) Income statement for 2026-01-01 through 2026-06-27. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **Services**: 9,899,000,000 US dollars - **Consumables**: 9,794,000,000 US dollars - **Instruments**: 3,305,000,000 US dollars - **Undisclosed (calculated)**: 1,000,000 US dollars - **Cost of revenues**: 13,687,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M. ## Chart details: Revenue by Business Segment (4 categories) - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement/revenue-by-business-segment-4-categories - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-revenue-by-business-segment-4-categories-sankey.png Income statement for 2026-01-01 through 2026-06-27. View: Business segment (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **Life Sciences Solutions**: 4,574,000,000 US dollars - **Analytical Instruments**: 3,466,000,000 US dollars - **Specialty Diagnostics**: 2,312,000,000 US dollars - **Laboratory Products and Biopharma Services**: 12,647,000,000 US dollars - **Cost of revenues**: 13,687,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. - **Life Sciences Solutions costs (calculated)**: 3,456,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Analytical Instruments costs (calculated)**: 2,784,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Specialty Diagnostics costs (calculated)**: 1,700,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Laboratory Products and Biopharma Services costs (calculated)**: 11,015,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 94,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M. ## Chart details: Revenue by Business Segment (5 categories) - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement/revenue-by-business-segment-5-categories - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-revenue-by-business-segment-5-categories-sankey.png Income statement for 2026-01-01 through 2026-06-27. View: Business segment (5 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **Life Sciences Solutions**: 5,450,000,000 US dollars - **Analytical Instruments**: 3,563,000,000 US dollars - **Specialty Diagnostics**: 2,346,000,000 US dollars - **Laboratory Products and Biopharma Services**: 12,729,000,000 US dollars - **Cost of revenues**: 13,687,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Revenue before reconciliation (calculated)**: 24,088,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Elimination of intersegment revenues**: negative 1,089,000,000 US dollars. Reported reconciliation to consolidated revenue. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. - **Life Sciences Solutions costs (calculated)**: 3,456,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Analytical Instruments costs (calculated)**: 2,784,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Specialty Diagnostics costs (calculated)**: 1,700,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Laboratory Products and Biopharma Services costs (calculated)**: 11,015,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 94,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M. ## Chart details: Revenue by Product and Service (2 categories) - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-2-categories - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-revenue-by-product-and-service-2-categories-sankey.png Income statement for 2026-01-01 through 2026-06-27. View: Product and service (2 categories). Revenue and costs use their disclosed categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **Product revenues revenue**: 13,100,000,000 US dollars - **Service revenues revenue**: 9,899,000,000 US dollars - **Product revenues cost of revenue**: 6,723,000,000 US dollars - **Service revenues cost of revenue**: 6,964,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-revenue-by-geography-sankey.png Income statement for 2026-01-01 through 2026-06-27. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **North America**: 11,854,000,000 US dollars - **Europe**: 6,268,000,000 US dollars - **Asia-Pacific**: 4,075,000,000 US dollars - **Other regions**: 802,000,000 US dollars - **Cost of revenues**: 13,687,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M. ## Chart details: Revenue by Business Segment by Subsegment Eliminations - Page: https://plicit.ai/financials/tmo/fy2026-ytd-q2-income-statement/revenue-by-business-segment-by-subsegment-eliminations - Chart image: https://plicit.ai/charts/tmo-fy2026-ytd-q2-revenue-by-business-segment-by-subsegment-eliminations-sankey.png Income statement for 2026-01-01 through 2026-06-27. View: Segments by Subsegments Consolidation Items. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total revenues**: 22,999,000,000 US dollars - **Cost of revenue (calculated)**: 13,687,000,000 US dollars - **Gross profit (calculated)**: 9,312,000,000 US dollars - **Operating expenses (calculated)**: 5,362,000,000 US dollars - **Operating income**: 3,950,000,000 US dollars - **Other income (expense), net (calculated)**: negative 292,000,000 US dollars - **Income before income taxes**: 3,658,000,000 US dollars - **Benefit from/(provision for) income taxes**: 238,000,000 US dollars - **Net income**: 3,397,000,000 US dollars - **Analytical Instruments**: 3,563,000,000 US dollars - **Life Sciences Solutions**: 5,450,000,000 US dollars - **Undisclosed (calculated)**: 14,599,000,000 US dollars - **Cost of revenues**: 13,687,000,000 US dollars - **Selling, general and administrative expenses**: 4,514,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Research and development expenses**: 700,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Restructuring and other costs**: 147,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn. - **Revenue before reconciliation (calculated)**: 23,612,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Laboratory Products and Biopharma Services - Intersubsegment Eliminations**: negative 468,000,000 US dollars. Reported reconciliation to consolidated revenue. - **Specialty Diagnostics - Intersubsegment Eliminations**: negative 145,000,000 US dollars. Reported reconciliation to consolidated revenue. - **Equity in earnings/(losses) of unconsolidated entities**: negative 23,000,000 US dollars. Reported below-tax contribution to net income. - **Analytical Instruments costs (calculated)**: 2,784,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Life Sciences Solutions costs (calculated)**: 3,456,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Laboratory Products and Biopharma Services - Intersubsegment Eliminations costs (calculated)**: 11,015,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Specialty Diagnostics - Intersubsegment Eliminations costs (calculated)**: 1,700,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 94,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue. - Of which attributable to THERMO FISHER SCIENTIFIC INC.: $3.39 B; to noncontrolling interests: $10.00 M.